Authors: | Bartelink, H.; Benz, C.; Cleveland, D.; Dorn, R.; Gralow, J.; Gradishar, W. J.; Grant, K.; Heimann, R.; Hellman, S.; Hudis, C.; Kerbel, R.; Lippman, M.; Lung, J.; Posner, M. C.; Steeg, P.; Vestal, R.; Weichselbaum, R. R.; Zetter, B. |
Article Title: | Expedition Inspiration Fund for Breast Cancer Research Meeting 2003 |
Keywords: | vasculotropin; thalidomide; disease course; angiogenesis inhibitor; bevacizumab; side effect; antineoplastic agents; conference paper; pathophysiology; capecitabine; paclitaxel; research design; methotrexate; antineoplastic agent; biological markers; imatinib; metastasis; breast cancer; cyclophosphamide; breast neoplasms; cancer research; prediction; financial management; medical research; neoplasm metastasis; gene therapy; tamoxifen; mucin 1; taxane derivative; estrogen receptor; trastuzumab; navelbine; epidermal growth factor derivative; retinoid; cytochrome p450; virus vector; genetic regulation; multidrug resistance protein 1; pharmacogenomics; humans; prognosis; human; female; priority journal |
Journal Title: | Breast Cancer Research and Treatment |
Volume: | 80 |
Issue: | 2 |
ISSN: | 0167-6806 |
Publisher: | Springer |
Date Published: | 2003-07-01 |
Start Page: | 139 |
End Page: | 144 |
Language: | English |
DOI: | 10.1023/a:1024529119454 |
PUBMED: | 12908816 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Export Date: 25 September 2014 -- Source: Scopus |